Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy

Clinical trial NCT04504396 · COMPLETED

Trial details

NCT number: NCT04504396
Sponsor: PegBio Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)

Start date: 2020-06-23
Primary completion: 2022-09-15
Enrollment: 620

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.